Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Chapter 2.1 > Flashcards

Chapter 2.1 Flashcards

1
Q
  1. Identify the three families of endogenous opioids
A

a. Endorphins
b. Enkephalins
c. Dynorphins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. List the functions of endogenous opioids
A

a. Help regulate the immune system, GI function, and cardiovasculature response
b. Involved in aspects of behavior, response to stress, eating/drinking behavior and psychological addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. List the functions of the three primary classes of opioid receptors
A

a. Mu, kappa and delta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. State the indications for the use of opioid (narcotic)
A

a. Acute pain (surgery or some trauma)

b. Chronic pain (Long-term conditions, chronic MSK pain, advanced CXs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Classify the following opioids as strong agonist, moderate agonist, antagonist
    Strong agonist
A

morphine, fentanyl, tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

moderate agonist

A

codeine, oxycodone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antagonist

A

naloxone, naltrexone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mixed agonist/antagonist

A

butorphanol, and nalbuphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. State the primary and secondary mechanisms of action of the opioids
A

a. Primary: effects certain pain pathways (dorsal horn of the spinal cord)
b. Secondary: effects the sensitivity of the peripheral neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Identify the sites of opioid effects in the human body
A

a. Spinal cord
b. Brain
c. Peripheral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. State the relationship between dosing schedule and the clinical effectiveness of opioid analgesics
A

a. Orally administered opioids are more effective when given at regularly scheduled intervals rather than when the pt. feels the need for them
b. Provides optimal pain relief (plasma concentrations will be maintained this way)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Identify the relatively minor and more serious adverse effects associated with opioid analgesics
A

a. Minor: mental slowing, sedation, mood changes, drowsiness, confusion, GI distress, vomiting, constipation
b. Major: respiratory depression, orthostatic hypertension, severe constipation, addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Define the following terms: tolerance, dependence, and addiction.
A

a. Tolerance: the need to progressively increase the dosage of a drug to achieve a therapeutic effect when the drug is used for a prolonged period
b. Dependence: the onset of withdrawal symptoms when the drug is abruptly removed
c. Addiction: when a pt. repeatedly ingests certain substances for mood-altering and pleasurable experiences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. List the physical symptoms of opioid withdrawal
A

a. Body aches, diarrhea, fever, gooseflesh, insomnia, irritability, loss of appetite, nausea, runny nose, shivering, sneezing, stomach cramps, leg cramps, sweating, tachycardia, uncontrollable yawning, fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. State the time course of withdrawal symptoms after the discontinuation of an opioid analgesic in a patient who is physically dependent on the opioid
A

a. Withdrawal symptoms occur 6-10 hrs after the last dose of the drug
b. Symptoms reach their peak in the 2nd/3rd day of stopping
c. Symptoms can last approx. 5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. State the role of the following agents in the management of opioid withdrawal and addiction: clonidine
A

symptomatic treatment, brainstem, slows down sympathetic outflow. Dials people down as well

17
Q

methadone

A

primary pharmacological intervention. Strong opioid agonist; treating opioid addiction w/ another opioid. This drug is substituted and is then slowly withdrawn

18
Q

buprenorphine

A

mixed agonist/antagonist. Partially stimulates mu opioid receptors/strongly antagonizes kappa opioid receptors.

19
Q

naloxone

A

opioid antagonist. Can be combined w/ Buprenorphine for addiction treatment

20
Q
  1. State factors associated with risk for addiction to opioid analgesics
A

a. Genetic predisposition

b. History of addiction (including alcohol abuse)

21
Q
  1. List the factors indicating minimal risk for addiction to opioid analgesics.
A

a. Pt. does not have history of substance abuse
b. Pain is “psychological”
c. Dosage matches pts pain levels

22
Q
  1. State the pharmacokinetic basis for using patient-controlled analgesia (PCA
A

a. Analgesic drugs should be delivered into the bloodstream via IV or other target tissue

23
Q
  1. Define the following terms and concepts used in PCA: loading dose
A

a single large dose that is given to establish analgesia

24
Q

demand dose

A

how much of the drug is given each time the pump is activated (usually very small doses)

25
Q

lockout interval

A

how much time has to elapse before the pump can be activated again (usually short periods)

26
Q

background infusion rate

A

a small amount of the drug is infused continuously to maintain the level of analgesia

27
Q

successful versus total demands

A

Tells the PCPs whether the pt. is wanting to get high, or if the dosage is not good enough

28
Q

1- and 4-hour limits

A

some PCS systems can be set to limit the total amount of drug given in a 1- or 4- hour period

29
Q
  1. Describe the following administration routes used for PCA: IV PCA
A

most common, administered by inserting a needle into the peripheral vein and then connecting the needle to a catheter/IV line

30
Q

epidural PCA

A

inserted into the area outside of the meninges surrounding the spinal cord by inserting a small catheter so the tip lies in the epidural space

31
Q

spinal (or intrathecal) PCA

A

same as above, however the tip of the catheter is placed in the subarachnoid space

32
Q

regional PCA

A

medication administered directly into a specific site such as a joint, peripheral nerve, or into a wound. Very localized

33
Q

transdermal PCA

A

medication is delivered through the skin transdermally into the systemic circulation. Electrical burst facilitates this

34
Q
  1. State the benefits of PCA
A

a. Allow better pain control w/ fewer side effects
b. Less sedation, tolerance, dependence
c. Increases pt. satisfaction

35
Q
  1. Define opioid-induced hyperalgesia.
A

a. Opioids may be ineffective or increase pain in certain pts.
b. Why this happens is unclear

36
Q
  1. State the concerns of a physical therapist working with a patient whose pain is managed by opioid analgesics administered orally, intravenously, or via PCA.
A

a. Be alert from orthostatic hypotension
b. Monitor signs of respiration depression
c. Monitor pain levels
d. Watch for signs of abuse of the drug

Pharmacology (22 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions